{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:00:38Z","timestamp":1785150038447,"version":"3.55.0"},"reference-count":22,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Metabolic remodeling is increasingly recognized as a key component of cardiomyopathy, yet the circulating organic acid profile associated with this condition remains incompletely characterized. In this case\u2013control study, we investigated differences in circulating organic acid profiles between patients with cardiomyopathy and control participants using targeted liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS). A total of 160 participants were enrolled, including 80 patients with cardiomyopathy and 80 age- and sex-comparable control participants. Circulating organic acids were quantitatively analyzed, and between-group differences were assessed using the two-sided Mann\u2013Whitney U test with Benjamini\u2013Hochberg false discovery rate correction; effect sizes were estimated using Cliff\u2019s delta. Detection rates were also examined because several metabolites included values below the assay limit of detection. Sixteen metabolites remained significant after correction. Among these, 3-hydroxyisovaleric acid demonstrated the largest increase, followed by 2-oxoglutaric acid and 2-methylcitric acid. Additional elevations were observed in citric acid, malic acid, N-acetylaspartic acid, fumaric acid, and suberic acid, whereas 2-oxoadipic acid was reduced. These alterations are consistent with perturbations in mitochondrial intermediary metabolism, branched-chain amino acid catabolism, ketone body metabolism, and tricarboxylic acid cycle-related pathways. However, because comorbidities, renal function, glycemic status, and medication use differed between groups, the findings should be interpreted as phenotype-associated metabolic signals rather than cardiomyopathy-specific causal effects or validated diagnostic biomarkers. In conclusion, targeted LC-MS\/MS-based organic acid profiling reveals an altered circulating metabolic pattern in cardiomyopathy, although further prospective studies with individual-level adjustment and external validation are required to determine its clinical relevance.<\/jats:p>","DOI":"10.3390\/jcdd13080350","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:47:41Z","timestamp":1785145661000},"page":"350","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Organic Acid Profiles in Non-Ischaemic Cardiomyopathy: A Case\u2013Control Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Yasemin","family":"Behram Kandemir","sequence":"first","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine, Istanbul Aydin University, Istanbul 34295, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Koyuncu","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Harran University, Sanliurfa 63050, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unal","family":"Guntekin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Akdeniz University, Antalya 07070, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veysel","family":"Tosun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mehmet Akif Inan Education and Research Hospital, Sanliurfa 63050, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-455X","authenticated-orcid":false,"given":"Necmettin","family":"Korucuk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Antalya City Hospital, Antalya 07080, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2221-8775","authenticated-orcid":false,"given":"Eyyup","family":"Tusun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mehmet Akif Inan Education and Research Hospital, Sanliurfa 63050, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Doganozu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Akdeniz University, Antalya 07070, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"H597","DOI":"10.1152\/ajpheart.00731.2016","article-title":"Metabolic remodeling in hypertrophied and failing myocardium: A review","volume":"313","author":"Peterzan","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/cvr\/cvae231","article-title":"Advances in myocardial energy metabolism: Metabolic remodelling in heart failure and beyond","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"122137","DOI":"10.1016\/j.lfs.2023.122137","article-title":"Metabolomics and mitochondrial dysfunction in cardiometabolic disease","volume":"333","author":"Shastry","year":"2023","journal-title":"Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"30.2.1","DOI":"10.1002\/0471142727.mb3002s98","article-title":"Targeted metabolomics","volume":"98","author":"Roberts","year":"2012","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhang, L., Zheng, J., Johnson, M., Mandal, R., Cruz, M., Mart\u00ednez-Hu\u00e9lamo, M., Andres-Lacueva, C., and Wishart, D.S. (2024). A comprehensive LC\u2013MS metabolomics assay for quantitative analysis of serum and plasma. Metabolites, 14.","DOI":"10.3390\/metabo14110622"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e003190","DOI":"10.1161\/JAHA.115.003190","article-title":"Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction","volume":"5","author":"Hunter","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zordoky, B.N., Sung, M.M., Ezekowitz, J., Mandal, R., Han, B., Bjorndahl, T.C., Bouatra, S., Anderson, T., Oudit, G.Y., and Wishart, D.S. (2015). Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124844"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"pbad005","DOI":"10.1093\/pcmedi\/pbad005","article-title":"Circulating metabolic signatures of heart failure in precision cardiology","volume":"6","author":"Xie","year":"2023","journal-title":"Precis. Clin. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jacbts.2024.04.008","article-title":"Towards metabolomic-based precision approaches for classifying and treating heart failure","volume":"9","author":"Hahn","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jchf.2017.07.009","article-title":"Targeted metabolomic profiling of plasma and survival in heart failure patients","volume":"5","author":"Lanfear","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ehf2.15285","article-title":"Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction","volume":"12","author":"Naeem","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10557-022-07320-4","article-title":"Branched-chain amino acid metabolism in the failing heart","volume":"37","author":"Karwi","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.numecd.2023.01.002","article-title":"Circulating citric acid cycle metabolites and risk of cardiovascular disease in the PREDIMED study","volume":"33","author":"Santos","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000524722","article-title":"Metabolic and metabolomics insights into dilated cardiomyopathy","volume":"78","author":"Ampong","year":"2022","journal-title":"Ann. Nutr. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbabio.2018.05.001","article-title":"Evidence for functional and regulatory cross-talk between the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex and 2-oxoadipate dehydrogenase","volume":"1859","author":"Nemeria","year":"2018","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nemeria, N.S., Nagy, B., Sanchez, R., Zhang, X., Leandro, J., Ambrus, A., Houten, S.M., and Jordan, F. (2022). Functional versatility of the human 2-oxoadipate dehydrogenase. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158213"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhao, J., Yang, S., Jing, R., Jin, H., Hu, Y., Wang, J., Gu, M., Niu, H., Zhang, S., and Chen, L. (2020). Plasma metabolomic profiles differentiate patients with dilated cardiomyopathy and ischemic cardiomyopathy. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.597546"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/350\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:16:17Z","timestamp":1785147377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcdd13080350"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13080350","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}